9-[N^δ-(2'-bromoacetyl)-δ-aminobutylamino]-1,2,3,4-tetrahydroacridine | 1011297-36-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 9-[N^δ-(2'-bromoacetyl)-δ-aminobutylamino]-1,2,3,4-tetrahydroacridine
• 英文别名: 2-bromo-N-[4-(1,2,3,4-tetrahydroacridin-9-ylamino)butyl]acetamide
• CAS: 1011297-36-1
• 化学式: C₁₉H₂₄BrN₃O
• 分子量: 390.323
• InChiKey: MVYANANVLBZPSY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  24
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  54
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  9-[N^δ-(2'-bromoacetyl)-δ-aminobutylamino]-1,2,3,4-tetrahydroacridine 在 silver nitrate 作用下， 以 乙腈 为溶剂， 反应 18.0h， 以56%的产率得到[2-Oxo-2-[4-(1,2,3,4-tetrahydroacridin-9-ylamino)butylamino]ethyl] nitrate
  参考文献：
  名称：

  Synthesis and Biological Evaluation of NO-Donor-Tacrine Hybrids as Hepatoprotective Anti-Alzheimer Drug Candidates

  摘要：

  In search of safer anti-Alzheimer drugs, 14 NO-donor-tacrine hybrids (1-14) were synthesized and evaluated for their ability to inhibit cholinesterases and for vasorelaxation effects. Compounds 1-13 showed good cholinesterases inhibitory activities in vitro, while 14, particularly, was highly selective, preferring butyrylcholinesterase rather than acetylcholinesterase. Four selected compounds (1, 9, 11, and 14) moderately relaxed the porcine pulmonary arteries in organ bath. In the hepatotoxicity study, significant hepatotoxicity was caused by tacrine but not by 9.

  DOI：

  10.1021/jm701491k
• 作为产物：
  描述：

  溴乙酰氯 、 9-(4-aminobutylamino)-1,2,3,4-tetrahydroacridine 以 二氯甲烷 为溶剂， 反应 0.5h， 以61%的产率得到9-[N^δ-(2'-bromoacetyl)-δ-aminobutylamino]-1,2,3,4-tetrahydroacridine
  参考文献：
  名称：

  Synthesis and Biological Evaluation of NO-Donor-Tacrine Hybrids as Hepatoprotective Anti-Alzheimer Drug Candidates

  摘要：

  In search of safer anti-Alzheimer drugs, 14 NO-donor-tacrine hybrids (1-14) were synthesized and evaluated for their ability to inhibit cholinesterases and for vasorelaxation effects. Compounds 1-13 showed good cholinesterases inhibitory activities in vitro, while 14, particularly, was highly selective, preferring butyrylcholinesterase rather than acetylcholinesterase. Four selected compounds (1, 9, 11, and 14) moderately relaxed the porcine pulmonary arteries in organ bath. In the hepatotoxicity study, significant hepatotoxicity was caused by tacrine but not by 9.

  DOI：

  10.1021/jm701491k

文献信息

• Synthesis and Biological Evaluation of NO-Donor-Tacrine Hybrids as Hepatoprotective Anti-Alzheimer Drug Candidates
  作者：Lei Fang、Dorothea Appenroth、Michael Decker、Michael Kiehntopf、Carolin Roegler、Thomas Deufel、Christian Fleck、Sixun Peng、Yihua Zhang、Jochen Lehmann

  DOI：10.1021/jm701491k

  日期：2008.2.1

  In search of safer anti-Alzheimer drugs, 14 NO-donor-tacrine hybrids (1-14) were synthesized and evaluated for their ability to inhibit cholinesterases and for vasorelaxation effects. Compounds 1-13 showed good cholinesterases inhibitory activities in vitro, while 14, particularly, was highly selective, preferring butyrylcholinesterase rather than acetylcholinesterase. Four selected compounds (1, 9, 11, and 14) moderately relaxed the porcine pulmonary arteries in organ bath. In the hepatotoxicity study, significant hepatotoxicity was caused by tacrine but not by 9.
• Hybrid Molecules from Xanomeline and Tacrine: Enhanced Tacrine Actions on Cholinesterases and Muscarinic M₁ Receptors
  作者：Lei Fang、Sabine Jumpertz、Yihua Zhang、Dorothea Appenroth、Christian Fleck、Klaus Mohr、Christian Tränkle、Michael Decker

  DOI：10.1021/jm901616h

  日期：2010.3.11

  A set of amide- and amine-linked hybrid molecules comprising moieties of the orthosteric M-1 muscarinic receptor agonist xanomeline and the cholinesterase inhibitor and allosteric receptor modulator tacrine were prepared with varying spacer length of 10-17 atoms. The hybrids inhibited acetylcholinesterase with similar or higher potency compared to tacrine. M, receptor binding affinity was similar or higher relative to xanomeline and far higher relative to tacrine. Affinities hardly changed when the receptors' orthosteric site was Occupied by all inverse agonist ligand. When Occupied by the orthosteric activator acetylcholine, affinity for the hybrids declined to unmeasureably low levels. Hybrids did not activate M-1 receptors. In vivo studies assaying cognition impairment in rats induced by scopolamine revealed pronounced enhancement of scopolamine action. Taken together, instead of dualsteric (simultaneous allosteric/orthosteric) binding, the hybrids seem to prefer purely allosteric binding at the inactive M-1 receptor.